The store will not work correctly when cookies are disabled.
8-methyl-2-((pyridin-4-ylthio)methyl)quinazolin-4(3H)-one
ID: ALA5177845
PubChem CID: 155818515
Max Phase: Preclinical
Molecular Formula: C15H13N3OS
Molecular Weight: 283.36
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc2c(=O)[nH]c(CSc3ccncc3)nc12
Standard InChI: InChI=1S/C15H13N3OS/c1-10-3-2-4-12-14(10)17-13(18-15(12)19)9-20-11-5-7-16-8-6-11/h2-8H,9H2,1H3,(H,17,18,19)
Standard InChI Key: SLMCMRWSQKTOEX-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.8559 1.2369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1413 1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4295 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4295 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1395 0.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8559 0.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 1.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 1.2373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 -0.0002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 2.4751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -0.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -0.8256 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.4290 -1.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1438 -0.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -2.0632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1456 -2.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4290 -2.0669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1395 -0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 2 0
9 12 1 0
12 13 1 0
13 14 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
19 18 2 0
14 19 1 0
5 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.36 | Molecular Weight (Monoisotopic): 283.0779 | AlogP: 2.92 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.74 | CX Basic pKa: 5.40 | CX LogP: 2.06 | CX LogD: 2.07 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -1.64 |
References
1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281] |